Literature DB >> 11002760

ACP best practice no 162. The histological reporting of melanoma. Association of Clinical Pathologists.

E Calonje1.   

Abstract

The incidence of malignant melanoma has increased steadily over the past 30 years and this type of malignancy is the leading cause of death from cutaneous malignant disease. Cutaneous malignancies, including melanoma, can be detected at a very early stage and a cure is possible with prompt detection and treatment. In recent years, and mainly because of increased awareness of the early detection of melanoma, histopathologists have been exposed more and more to melanocytic lesions. Therefore, it is essential that histopathologists are able to provide a report to the clinician that conveys relevant information in a concise and precise manner. This paper provides a set of guidelines aimed at helping histopathologists with the gross and microscopic description and diagnosis of malignant melanoma.

Entities:  

Mesh:

Year:  2000        PMID: 11002760      PMCID: PMC1762936          DOI: 10.1136/jcp.53.8.587

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

Review 1.  Malignant melanoma. A multivariate analysis of prognostic factors.

Authors:  R T Vollmer
Journal:  Pathol Annu       Date:  1989

2.  The prognostic implications of microscopic satellites in patients with clinical stage I melanoma.

Authors:  P León; J M Daly; M Synnestvedt; D J Schultz; D E Elder; W H Clark
Journal:  Arch Surg       Date:  1991-12

Review 3.  Significance of DNA ploidy in cutaneous lesions.

Authors:  A J Herzberg
Journal:  Arch Dermatol       Date:  1992-05

4.  Recommendations for the reporting of tissues removed as part of the surgical treatment of cutaneous melanoma. Association of Directors of Anatomic and Surgical Pathology.

Authors:  A J Cochran; C Bailly; M Cook; K Crotty; M Mihm; W Mooi; R Sagebiel
Journal:  Hum Pathol       Date:  1997-10       Impact factor: 3.466

5.  Do histopathology reports of primary cutaneous melanoma contain enough essential information?

Authors:  J M Miller; D N Slater
Journal:  J Clin Pathol       Date:  1996-03       Impact factor: 3.411

Review 6.  Cutaneous melanoma: pathology, relevant prognostic indicators and progression.

Authors:  A Slominski; J Ross; M C Mihm
Journal:  Br Med Bull       Date:  1995-07       Impact factor: 4.291

7.  Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent.

Authors:  D Guerry; M Synnestvedt; D E Elder; D Schultz
Journal:  J Invest Dermatol       Date:  1993-03       Impact factor: 8.551

8.  Thin malignant melanomas with regression and metastases.

Authors:  S G Ronan; A M Eng; H A Briele; N N Shioura; T K Das Gupta
Journal:  Arch Dermatol       Date:  1987-10

9.  Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.

Authors:  J A Carlson; G R Dickersin; A J Sober; R L Barnhill
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

Review 10.  Tumour progression and the nature of cancer.

Authors:  W H Clark
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

View more
  3 in total

1.  Electronic publishing and internet learning.

Authors:  P J van Diest; H Holzel; M Reid; M Crook; G Spickett
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Canine olfactory detection of malignant melanoma.

Authors:  Leon Frederick Campbell; Luke Farmery; Susannah Mary Creighton George; Paul B J Farrant
Journal:  BMJ Case Rep       Date:  2013-10-14

3.  Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology.

Authors:  Anna Batistatou; Martin G Cook; Daniela Massi
Journal:  Virchows Arch       Date:  2009-04-08       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.